About Hope Pharmaceuticals
Hope Pharmaceuticals is a Healthcare company based in Scottsdale (United States) founded in 1996. Private company developing and commercializing antidotes to cyanide poisoning. Hope Pharmaceuticals offers products and services including Nithiodote Kits, Sodium Nitrite Injection, and Sodium Thiosulfate Injection. Its focus areas include Diversified Pharmaceuticals.
Company details
Hope Pharmaceuticals was founded in 1996 and is based in Scottsdale, United States. Operations focus on the pharmaceutical sector, where antidotes for cyanide poisoning are developed and commercialized. Two primary products are offered: NITHIDOTE, which combines Sodium Nitrite and Sodium Thiosulfate to address life-threatening hypotension and methemoglobin formation, and Sal-Tropine, used to reduce salivation in dental procedures. The company remains privately held.
- Headquarters Scottsdale, United States
- SectorsHealthcare
- Website hopepharm.com
- Latest Funding Round$1.9M (USD), Grant
Feb 2009
- Investors
Products & Services of Hope Pharmaceuticals
Hope Pharmaceuticals offers a comprehensive portfolio of products and services, including Nithiodote Kits, Sodium Nitrite Injection, and Sodium Thiosulfate Injection.
FDA-approved kit for emergency cyanide poisoning treatment.
Medication used to counteract cyanide effects in poisoning.
Component for treating cyanide poisoning alongside other drugs.
Funding Insights of Hope Pharmaceuticals
- Total Rounds 1
- Last Round Grant — $1.9M
- First Round $1.9M
(Feb 2009)
- Investors Count 1
All 1 funding rounds of Hope Pharmaceuticals with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2009 | $1.9M | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Hope Pharmaceuticals
Hope Pharmaceuticals has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for Hope Pharmaceuticals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Hope Pharmaceuticals
2 dated milestones of Hope Pharmaceuticals across 13 years, from founding to its latest funding, stage changes and deals.
- Founded Hope Pharmaceuticals is founded.
- Funding First funding round of $1.9M.
Web traffic of Hope Pharmaceuticals
Websites that share an audience with Hope Pharmaceuticals (hopepharm.com).
Websites whose visitors overlap most with Hope Pharmaceuticals. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| phoenixgroup.eu | 100% | 41.2K | #638,938 | View details | |
cyanokit.com | cyanokit.com | 88% | #3,912,158 | – | |
hopepharmaceuticals.cc | hopepharmaceuticals.cc | 45% | – |
Top companies in Pharmaceuticals & Distribution
3 companies that operate in the same segment as Hope Pharmaceuticals (Pharmaceuticals & Distribution) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | USD 33.23 B | 28,000 | ||
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | USD 5.33 B | 55,000 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Hope Pharmaceuticals
Complete news archive for Hope Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hope Pharmaceuticals
Hope Pharmaceuticals was founded in 1996 and raised its 1st funding round 13 years after it was founded.
Hope Pharmaceuticals is headquartered in Scottsdale, United States. It is registered at Scottsdale, Arizona, United States.
Hope Pharmaceuticals was founded in 1996 and is based in Scottsdale, United States. Operations focus on the pharmaceutical sector, where antidotes for cyanide poisoning are developed and commercialized. Two primary products are offered: NITHIDOTE, which combines Sodium Nitrite and Sodium Thiosulfate to address life-threatening hypotension and methemoglobin formation, and Sal-Tropine, used to reduce salivation in dental procedures. The company remains privately held.
Hope Pharmaceuticals offers Nithiodote Kits, Sodium Nitrite Injection, and Sodium Thiosulfate Injection.
Hope Pharmaceuticals has 1 investor. Key investors include HHS.